Breastfeeding decisions for women on antipsychotics are not all-or-nothing. Most second-generation antipsychotics enter breast milk in small amounts, and most have not been associated with clear adverse effects in breastfed infants. The harder question is usually not "is the medication compatible with breastfeeding?" but "what does the whole picture — sleep, stability, support, the parent's preferences — recommend?"
Most antipsychotics transfer into breast milk in small amounts, are generally considered compatible with breastfeeding when the mother's psychiatric stability is maintained, and decisions are best made with a perinatal psychiatrist using infant-specific risk and benefit data.
The basic principle
Three things matter when assessing a medication's compatibility with breastfeeding:
- How much of the drug enters breast milk (the milk-to-plasma ratio)
- How much the infant absorbs and metabolises (relative infant dose)
- What's been reported in actual infants exposed
The LactMed database from the National Library of Medicine is the standard reference, with up-to-date entries for nearly every psychiatric medication.
What we know about specific antipsychotics
Olanzapine
Relative infant dose is generally under 2%, which is well below the 10% threshold often cited for caution. Most case reports describe no adverse infant effects. Sedation in the infant is theoretically possible; close observation in the first weeks is reasonable.
Quetiapine
One of the lowest milk transfer rates among antipsychotics. Generally regarded as compatible. Some clinicians prefer it for breastfeeding mothers in part for this reason.
Risperidone and paliperidone
Both transfer in small amounts. Limited reports describe no adverse effects in exposed infants. Risperidone elevates prolactin, which can sometimes affect breastfeeding mothers' milk supply (in either direction).
Aripiprazole and brexpiprazole
Aripiprazole transfers in small amounts. There are reports of decreased milk supply in some women on aripiprazole, possibly because of its effect on dopamine and prolactin. If supply is a concern, this can be discussed with the prescriber.
Clozapine
Clozapine accumulates in breast milk and has been associated with sedation, agranulocytosis risk concerns, and seizure risk in exposed infants. Most authorities — including LactMed — recommend against breastfeeding while on clozapine.
First-generation antipsychotics
Haloperidol and chlorpromazine have been used in breastfeeding for decades. Small amounts transfer; chlorpromazine has more reports of infant sedation than haloperidol.
Long-acting injectables
Data are limited. The pharmacokinetics — slow release over weeks — make abrupt removal of exposure impossible. Decisions are individualised.
What to watch for in the infant
Infants exposed to antipsychotics through breast milk should be observed for:
- Sedation, poor feeding, or floppiness
- Tremor, stiffness, or abnormal movements
- Slow weight gain
- Premature or low-birth-weight infants metabolise drugs more slowly and warrant closer observation
Routine paediatric care covers most of this. Any concerns should be raised with the paediatrician immediately.
The parental side of the decision
Breastfeeding has real benefits for mother and baby. So does the mother's mental stability. For some women, breastfeeding fits well into their postpartum life and supports bonding. For others, the demands of overnight feeds threaten the sleep that keeps psychosis at bay. There is no universally right choice. ACOG explicitly supports both decisions when made with care.
When formula is the better choice
Formula is sometimes the safest option, especially when:
- The mother is on a medication with significant infant risk (e.g., clozapine)
- Sleep protection is critical to maintaining stability
- The mother is in early postpartum recovery from psychosis or severe depression
- The mother prefers it
Choosing formula is not a moral failing. It is sometimes the choice that keeps the family well.
Combination feeding
Many women combine breastfeeding and formula. This can preserve some bonding and immunological benefit while allowing the partner to take overnight feeds and protect sleep. It is also a useful approach when the mother is recovering from a peripartum episode.
For women with schizophrenia, protected sleep in the postpartum is a clinical priority — not a luxury. Any feeding plan should account for sleep protection.
Practical questions to ask
- What does LactMed say about my specific medication?
- Is my baby preterm or otherwise medically complex?
- Who will help with overnight feeds?
- What signs in the baby would prompt a paediatric visit?
- How will we monitor my own stability while breastfeeding?
Resources
The bottom line
For most second-generation antipsychotics, breastfeeding is a reasonable option with sensible monitoring. Clozapine is the main exception. The most important inputs to the decision are not just the medication but the mother's stability, support system, and preferences. A well-supported formula-feeding mother is healthier for her baby than an unwell breastfeeding one — and the reverse is also true. The decision belongs to the parent, made with good information.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.